EDGAR Filing Documents for 0001628280-18-010933

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001628280-18-010933

Filing Date

2018-08-09

Accepted

2018-08-09 16:05:38

Documents

Period of Report

2018-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	auph-0630186xk.htm	6-K	17949
2	EXHIBIT 99.1	exhibit991-interimconsolid.htm	EX-99.1	782314
3	EXHIBIT 99.2	exhibit992-mda06302018.htm	EX-99.2	311001
4	EXHIBIT 99.3	exhibit993-certificationof.htm	EX-99.3	15870
5	EXHIBIT 99.4	exhibit994-certificationof.htm	EX-99.4	15875
6		aurinialogoa02.jpg	GRAPHIC	15156
7		q2financialstatementscover.jpg	GRAPHIC	70774
8		q2mdacovera01.jpg	GRAPHIC	71478
	Complete submission text file	0001628280-18-010933.txt		1355711

Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8

Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272

Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)